Activation of Wnt/β-Catenin Signaling Increases Apoptosis in Melanoma Cells Treated with Trail

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Zimmerman, Zachary F ^a   Kulikauskas, Rima M ^a   Bomsztyk, Karol ^a   Moon, Randall T ^a,b   Chien, Andy J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; B RAF KINASE; BETA CATENIN; BIM PROTEIN; CHIR 99021; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; PROTEIN BCL 2; PROTEIN MCL 1; PUMA PROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN; APOPTOSIS REGULATORY PROTEIN; AXIN1 PROTEIN, HUMAN; BBC3 PROTEIN, HUMAN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; GLYCOGEN SYNTHASE KINASE 3; MCL1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MYELOID LEUKEMIA FACTOR 1; ONCOPROTEIN; PROTEIN KINASE INHIBITOR; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; WNT3A PROTEIN, HUMAN; CULTURE MEDIUM;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; CULTURE TECHNIQUE; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; WNT SIGNALING PATHWAY; ANTAGONISTS AND INHIBITORS;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AXIN PROTEIN; BETA CATENIN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MELANOMA; MEMBRANE PROTEINS; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84880305558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069593     Document Type: Article

References (39)

1. Flaherty KT, Hodi FS, Fisher DE, (2012) From genes to drugs: targeted strategies for melanoma. Nat Rev Cancer 12: 349-361. doi:10.1038/nrc3218. PubMed: 22475929.
2. Thomas WD, Hersey P, (1998) TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol (Baltimore, Md: 1950161:: 2195-2200. PubMed: 9725211.
3. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163. doi:10.1038/5517. PubMed: 9930862.
4. Nguyen T, Thomas W, Zhang XD, Gray C, Hersey P, (2000) Immunologically-mediated tumour cell apoptosis: the role of TRAIL in T cell and cytokine-mediated responses to melanoma. Forum (Genova) 10: 243-252.
5. Nguyen T, Zhang XD, Hersey P, (2001) Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Clin Cancer Res 7: 966s-973s. PubMed: 11300498.
6. Ivanov VN, Bhoumik A, Ronai Z, (2003) Death receptors and melanoma resistance to apoptosis. Oncogene 22: 3152-3161. doi:10.1038/sj.onc.1206456. PubMed: 12789291.
7. Moon RT, Kohn AD, De Ferrari GV, Kaykas A, (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701. doi:10.1038/nrg1427. PubMed: 15372092.
8. Chien AJ, Conrad WH, Moon RT, (2009) A Wnt survival guide: from flies to human disease. J Invest Dermatol 129: 1614-1627. doi:10.1038/jid.2008.445. PubMed: 19177135.
9. Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, et al. (2009) Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci U S A 106: 1193-1198. doi:10.1073/pnas.0811902106. PubMed: 19144919.
10. Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, et al. (2001) Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 145: 210-216. doi:10.1046/j.1365-2133.2001.04336.x. PubMed: 11531781.
11. Lucero OM, Dawson DW, Moon RT, Chien AJ, (2010) A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers. Curr Oncol Rep 12: 314-318. doi:10.1007/s11912-010-0114-3. PubMed: 20603725.
12. Meyer S, Fuchs TJ, Bosserhoff AK, Hofstädter F, Pauer A, et al. (2012) A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLOS ONE 7: e38222. doi:10.1371/journal.pone.0038222. PubMed: 22685558.
13. Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, et al. (2007) Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev 21: 2923-2935. doi:10.1101/gad.450107. PubMed: 18006687.
14. Gallagher SJ, Rambow F, Kumasaka M, Champeval D, Bellacosa A, et al. (2012) Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene, 32: 2230-8. PubMed: 22665063.
15. Dorsky RI, Moon RT, Raible DW, (1998) Control of neural crest cell fate by the Wnt signalling pathway. Nature 396: 370-373. doi:10.1038/24620. PubMed: 9845073.
16. Dorsky RI, Raible DW, Moon RT, (2000) Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 14: 158-162. PubMed: 10652270.
17. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA, (2003) Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res Off J Am Assoc Cancer Res 9: 3383-3388. PubMed: 12960126.
18. Biechele TL, Kulikauskas RM, Toroni RA, Lucero OM, Swift RD, et al. (2012) Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma. Sci Signal 5ra3.
19. Piñon JD, Labi V, Egle A, Villunger A, (2008) Bim and Bmf in tissue homeostasis and malignant disease. Oncogene 27 (Suppl 1):: S41-S52. doi:10.1038/onc.2009.42. PubMed: 19641506.
20. Yu J, Zhang L, (2008) PUMA, a potent killer with or without p53. Oncogene 27 (Suppl 1):: S71-S83. doi:10.1038/onc.2009.45. PubMed: 19641508.
21. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, et al. (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172-1183. doi:10.1128/MCB.22.4.1172-1183.2002. PubMed: 11809808.
22. Chien AJ, Conrad WH, Moon RT, (2009) A Wnt survival guide: from flies to human disease. J Invest Dermatol 129: 1614-1627. doi:10.1038/jid.2008.445. PubMed: 19177135.
23. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, et al. (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277: 30998-31004. doi:10.1074/jbc.M204527200. PubMed: 12055200.
24. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, et al. (1997) The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181-192. doi:10.1016/S0092-8674(00)80324-4. PubMed: 9230313.
25. Smalley KS, Contractor R, Haass NK, Kulp AN, Atilla-Gokcumen GE, et al. (2007) An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. Cancer Res 67: 209-217.
26. John JK, Paraiso KH, Rebecca VW, Cantini LP, Abel EV, et al. (2012) GSK3β Inhibition Blocks Melanoma Cell/Host Interactions by Downregulating N-Cadherin Expression and Decreasing FAK Phosphorylation. J Invest Dermatol, 132: 2818-27. PubMed: 22810307.
27. Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, et al. (2003) Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell 12: 627-637. doi:10.1016/S1097-2765(03)00348-4. PubMed: 14527409.
28. Mamaghani S, Simpson CD, Cao PM, Cheung M, Chow S, et al. (2012) Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis. PLOS ONE 7: e41102. doi:10.1371/journal.pone.0041102. PubMed: 22829912.
29. Pollock PM, Meltzer PS, (2002) A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell 2: 5-7. doi:10.1016/S1535-6108(02)00089-2. PubMed: 12150818.
30. Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, et al. (1999) Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J Biol Chem 274: 10681-10684. doi:10.1074/jbc.274.16.10681. PubMed: 10196136.
31. Cha B, Kim W, Kim YK, Hwang BN, Park SY, et al. (2011) Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling. Oncogene, 30: 2379-89. PubMed: 21242974.
32. Huang S-MA, Mishina YM, Liu S, Cheung A, Stegmeier F, et al. (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614-620. doi:10.1038/nature08356. PubMed: 19759537.
33. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, et al. (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614-620. doi:10.1038/nature08356. PubMed: 19759537.
34. Zhang L, Ren X, Alt E, Bai X, Huang S, et al. (2010) Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature 464: 1058-1061. doi:10.1038/nature08871. PubMed: 20348907.
35. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195. doi:10.1038/40657. PubMed: 9217161.
36. Coureuil M, Ugolin N, Tavernier M, Chevillard S, Barroca V, et al. (2010) Puma and Trail/Dr5 pathways control radiation-induced apoptosis in distinct populations of testicular progenitors. PLOS ONE 5: e12134. doi:10.1371/journal.pone.0012134. PubMed: 20711434.
37. Zhang XD, Gillespie SK, Borrow JM, Hersey P, (2003) The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis. Biochem Pharmacol 66: 1537-1545. doi:10.1016/S0006-2952(03)00509-4. PubMed: 14555232.
38. Gillespie S, Borrow J, Zhang XD, Hersey P, (2006) Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells. Apoptosis 11: 2251-2265. doi:10.1007/s10495-006-0283-6. PubMed: 17051334.
39. Nelson J, Denisenko O, Bomsztyk K, (2009) The fast chromatin immunoprecipitation method. Methods Mol Biol 567: 45-57. doi:10.1007/978-1-60327-414-2_3. PubMed: 19588084.